Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 16 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Moderate alcohol consumption may reduce risk of dementia

A Dutch study in this week's issue of the Lancet suggests that light-to-moderate alcohol consumption could reduce the risk of dementia among older people, regardless of the type of alcoholic drink consumed.

News image

fiogf49gjkf04

Light-to-moderate alcohol consumption reduces the risk of coronary heart disease and stroke.

As vascular disease is associated with cognitive impairment and dementia, alcohol consumption might also affect the risk of dementia.

Monique Breteler and colleagues from Erasmus University Medical School, Rotterdam, Netherlands, examined the relation between alcohol consumption and the risk of dementia in individuals taking part in the Rotterdam Study. This prospective population-based study included around 8000 individuals, aged 55 years and older.

Participants who did not have dementia at the start of the study (from 1990 to 1993) and who had complete data on alcohol consumption were studied.

Adjusting for age, sex, systolic blood pressure, education, smoking, and body-mass index, the investigators compared the risk of developing dementia between individuals who regularly consumed alcohol with those who did not consume alcohol.

The average follow-up was 6 years.

Light-to-moderate alcohol consumption associated with a 42% risk reduction of all dementia.
Lancet

During this period, 197 individuals developed dementia (146 Alzheimer's disease, 29 vascular dementia, and 22 other dementia). The average alcohol consumption was 0.29 drinks per day.

Light-to-moderate alcohol consumption (1 to 3 drinks per day) was associated with a 42% risk reduction of all dementia, and around a 70% reduction in risk of vascular dementia.

Risk reduction was not related to the type of alcoholic drink consumed.

The investigators suggest that several mechanisms could explain the study findings.

Firstly, alcohol might reduce the cardiovascular risk profile - ethanol is known to reduce platelet aggregation - or by altering the blood-lipid ratio.

Secondly, they suggest that light-to-moderate alcohol intake might have a direct effect on cognition by stimulating the release of acetylcholine in the hippocampus area of the brain. Acetylcholine is known to facilitate memory and learning processes; however, high alcohol intake inhibits acetylcholine production.

Dr Breteler comments, "In recent years evidence has been accumulating that vascular factors may be involved in the cause of dementia, both vascular dementia and Alzheimer's disease.

"Our findings lend further support to the vascular hypothesis of dementia.

"We saw some indication for a stronger relation with alcohol in persons with a genetically determined susceptibility for Alzheimer's disease."

"Our findings can help focus research into the specific mechanisms that underlie the development of dementing illnesses," she concluded.

Lancet 2002; 359(9303): 281
25 January 2002

Go to top of page Email this page Email this page to a colleague

 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 20 December 2017 
Management of abnormal liver blood tests
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure
 06 December 2017 
Preventing hepatic encephalopathy-related readmissions
 05 December 2017 
Thiopurines and colorectal cancer in IBD
 05 December 2017 
Childhood obesity into adulthood

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us